NCT01849952 Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas Status TERMINATED Phase N/A
NCT01802567 Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer Status COMPLETED Phase NA
NCT01518413 Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT01445691 More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery Status WITHDRAWN Phase PHASE2
NCT01445314 Analysis of Data Collected From Individuals Administered Neurobehavioral Assessments Status COMPLETED Phase N/A
NCT01342237 Tandem High Dose Chemotherapy and Autologous Stem Cell Rescue for High Risk Pediatric Brain Tumors Status UNKNOWN Phase PHASE2
NCT01288573 A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone Status COMPLETED Phase PHASE1/PHASE2
NCT01259479 Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors Status COMPLETED Phase PHASE1
NCT01222780 To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer Status COMPLETED Phase PHASE1
NCT01212237 Dose Response of Functionally Critical Brain Regions for Brain Radiotherapy Status WITHDRAWN Phase N/A
NCT01188096 A Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas Status COMPLETED Phase PHASE2
NCT01117168 Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01115777 Prospective Assessment of Quality of Life (QOL) in Pediatric Patients Treated With Radiation Therapy for Brain Tumors and Non-central Nervous System (Non-CNS) Malignancies Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01100658 Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors Status TERMINATED Phase NA
NCT01032200 Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors Status COMPLETED Phase PHASE2